In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Thermo Fisher Scientific Inc’s stock clocked out at $563.07, down -0.90% from its previous closing price of $568.21. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 1.38 million shares were traded. TMO stock price reached its highest trading level at $575.245 during the session, while it also had its lowest trading level at $561.91.
Ratios:
To gain a deeper understanding of TMO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.62. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on December 09, 2025, initiated with a Buy rating and assigned the stock a target price of $685.
On December 08, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $750.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 04 ’25 when Lagarde Michel sold 22,046 shares for $563.56 per share. The transaction valued at 12,424,244 led to the insider holds 84,117 shares of the business.
Lagarde Michel sold 32,000 shares of TMO for $18,668,526 on Dec 03 ’25. The Executive Vice President & COO now owns 65,480 shares after completing the transaction at $583.39 per share. On Dec 02 ’25, another insider, Lagarde Michel, who serves as the Executive Vice President & COO of the company, sold 30,000 shares for $581.92 each. As a result, the insider received 17,457,600 and left with 29,480 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMO now has a Market Capitalization of 211549945856 and an Enterprise Value of 247464312832. As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.53, and their Forward P/E ratio for the next fiscal year is 22.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.84 while its Price-to-Book (P/B) ratio in mrq is 4.15. Its current Enterprise Value per Revenue stands at 5.658 whereas that against EBITDA is 22.839.
Stock Price History:
The Beta on a monthly basis for TMO is 0.91, which has changed by 0.06334686 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, TMO has reached a high of $610.97, while it has fallen to a 52-week low of $385.46. The 50-Day Moving Average of the stock is 0.37%, while the 200-Day Moving Average is calculated to be 16.98%.
Shares Statistics:
It appears that TMO traded 2.04M shares on average per day over the past three months and 1651870 shares per day over the past ten days. A total of 375.71M shares are outstanding, with a floating share count of 374.88M. Insiders hold about 0.22% of the company’s shares, while institutions hold 91.83% stake in the company. Shares short for TMO as of 1763078400 were 5462612 with a Short Ratio of 2.68, compared to 1760486400 on 3908166. Therefore, it implies a Short% of Shares Outstanding of 5462612 and a Short% of Float of 1.46.
Dividends & Splits
With its trailing 12-month dividend rate of 1.68, TMO has a forward annual dividend rate of 1.68. Against a Trailing Annual Dividend Yield of 0.0029566532. The stock’s 5-year Average Dividend Yield is 0.24. The current Payout Ratio is 9.43% for TMO, which recently paid a dividend on 2025-09-15 with an ex-dividend date of 2025-12-15. Stock splits for the company last occurred on 1996-06-06 when the company split stock in a 3:2 ratio.
Earnings Estimates
A detailed examination of Thermo Fisher Scientific Inc (TMO) is currently in progress, with 21.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $5.59, with high estimates of $5.84 and low estimates of $5.38.
Analysts are recommending an EPS of between $22.81 and $22.51 for the fiscal current year, implying an average EPS of $22.73. EPS for the following year is $24.65, with 27.0 analysts recommending between $25.87 and $24.0.
Revenue Estimates
In. The current quarter, 19 analysts expect revenue to total $11.95B. It ranges from a high estimate of $12.01B to a low estimate of $11.82B. As of. The current estimate, Thermo Fisher Scientific Inc’s year-ago sales were $11.39BFor the next quarter, 19 analysts are estimating revenue of $11.03B. There is a high estimate of $11.25B for the next quarter, whereas the lowest estimate is $10.87B.
A total of 25 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $44.44B, while the lowest revenue estimate was $43.71B, resulting in an average revenue estimate of $44.26B. In the same quarter a year ago, actual revenue was $42.88BBased on 25 analysts’ estimates, the company’s revenue will be $46.52B in the next fiscal year. The high estimate is $46.93B and the low estimate is $46.01B.
